Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - CVS HEALTH Corp | cvs-20180930ex322bd0772.htm |
| EX-32.1 - EX-32.1 - CVS HEALTH Corp | cvs-20180930ex321dc5eeb.htm |
| EX-31.2 - EX-31.2 - CVS HEALTH Corp | cvs-20180930ex312b5b169.htm |
| EX-31.1 - EX-31.1 - CVS HEALTH Corp | cvs-20180930ex311905477.htm |
| EX-10.1 - EX-10.1 - CVS HEALTH Corp | cvs-20180930ex1014b1084.htm |
| 10-Q - 10-Q - CVS HEALTH Corp | cvs-20180930x10q.htm |
Letter re: Unaudited Interim Financial Information
November 6, 2018
To the Shareholders and the Board of Directors of CVS Health Corporation
We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-217596, Form S-4 No. 333-222412, Form S-8 Nos. 333-49407, 333-34927, 333-28043, 333-91253, 333-63664, 333-139470, 333-141481, 333-167746, 333-208805, and 333-217853) of CVS Health Corporation of our report dated November 6, 2018, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that are included in its Form 10-Q for the quarter ended September 30, 2018.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
Boston, Massachusetts |
|